hodgkins disease
Item
females diagnosed with hodgkin's disease at age < 35 years
boolean
C0019829 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
mantle or chest radiation
Item
> 5 years from mantle or chest radiation
boolean
C1522449 (UMLS CUI [1,1])
C3846131 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0817096 (UMLS CUI [2,2])
age
Item
current age > 30 years
boolean
C0001779 (UMLS CUI [1])
completed childbearing
Item
has completed childbearing
boolean
C3831118 (UMLS CUI [1])
discontinue use of oral contraceptives
Item
willingness to discontinue use of oral contraceptives or other hormonal contraception for duration of the study
boolean
C0009905 (UMLS CUI [1])
secondary malignancy
Item
history of secondary malignancy after hodgkin's disease, except thyroid cancer of basal cell cancer
boolean
C3266877 (UMLS CUI [1])
recurrence of hodgkin disease
Item
recurrence of hodgkin's disease in the 5 years before study entry
boolean
C2825055 (UMLS CUI [1,1])
C0019829 (UMLS CUI [1,2])
participation in other study
Item
current participation in any other cancer prevention study
boolean
C2348568 (UMLS CUI [1])
tamoxifen
Item
current or prior use of tamoxifen
boolean
C0039286 (UMLS CUI [1])
coumadin
Item
current use of coumadin
boolean
C0699129 (UMLS CUI [1])
history of deep venous thrombosis
Item
history of deep venous thrombosis, pulmonary embolism, or a condition known to be associated with hypercoagulability
boolean
C0149871 (UMLS CUI [1])
C0034065 (UMLS CUI [2])
cerebrovascular accident
Item
history of cerebrovascular accident
boolean
C0038454 (UMLS CUI [1])
macular degeneration
Item
history of macular degeneration
boolean
C0024437 (UMLS CUI [1])
chemotherapy for benign disease
Item
current use of chemotherapy for benign disease
boolean
C0392920 (UMLS CUI [1,1])
C0086692 (UMLS CUI [1,2])